Both in Pharmaceuticals
Atrium Therapeutics vs Journey Medical
Over the past year RNA returned −88.2% and DERM returned −39.3%; their daily moves had a correlation of 0.13.
RNA −88.2% DERM −39.3%Growth of $1, one year, split-adjusted
| Metric | RNA | DERM |
|---|---|---|
| Price | $8.27 | $5.17 |
| Market cap | $141.5M | $145.9M |
| Today | +0.12% | −4.44% |
| 1 month | +1.6% | −23.1% |
| 6 months | −38.4% | −0.4% |
| Year to date | −88.5% | −32.9% |
| 1 year | — | −34.9% |
| Revenue growth (YoY) | −21.9% | +18.9% |
| Gross margin | 100.0% | 65.6% |
| Net margin | −672.0% | −1.7% |
| P/E (TTM) | — | — |
| Price / sales | 3.9× | 2.2× |
| Net cash | $263.9M | -$245.0K |
| Dividend yield | — | — |
| Volatility (60d) | 65.3% | 62.4% |
| Short % of float | 22.9% | 24.8% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).